Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults
NCT ID: NCT00763724
Last Updated: 2010-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
254432 participants
OBSERVATIONAL
2008-06-30
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
NCT00042562
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
NCT00073411
A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
NCT00406848
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
NCT00422162
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Duloxetine
No interventions assigned to this group
2
Venlafaxine
No interventions assigned to this group
3
SSRI
No interventions assigned to this group
4
TCA
No interventions assigned to this group
5
Multiple Antidepressants
No interventions assigned to this group
6
Depressed (not antidepressant treated)
No interventions assigned to this group
7
General population
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least 6 months of continuous enrollment data prior to index date.
* Have complete medical, facility, and pharmacy records (the latter of which will include complete quantity and days supplied information).
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eli Lilly
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 317-615-4559 Mon-Fri 9am - 5pm Eastern time (UTC/GMT - 5 hours, EST)
Role: STUDY_DIRECTOR
Eli Lilly and Company
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F1J-MC-B027
Identifier Type: -
Identifier Source: secondary_id
12016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.